Keywords: elan, drops, new, tysabri, pml, case, shares

Elan drops 3.6% on new Tysabri PML case

Article | 22 December 2008

Print This

Shares in Irish biotechnology firm Elan fell 3.6% on December 15 after it was reported that another patient taking its lead product, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in